Chinese General Practice ›› 2023, Vol. 26 ›› Issue (30): 3791-3796.DOI: 10.12114/j.issn.1007-9572.2023.0198
• Original Research • Previous Articles Next Articles
Received:
2023-02-27
Revised:
2023-05-15
Published:
2023-10-20
Online:
2023-05-31
Contact:
REN Fuxian, GAO Dengfeng
通讯作者:
任付先, 高登峰
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0198
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 性别(男/女) | 住院时间〔M(P25,P75),d〕 | 感染〔例(%)〕 | 糖尿病〔例(%)〕 | 高血压〔例(%)〕 | 慢性阻塞性肺疾病〔例(%)〕 | |
---|---|---|---|---|---|---|---|---|---|
生存组 | 564 | 72.9(64.9,80.5) | 317/247 | 7(5,9) | 191(33.9) | 197(34.9) | 342(60.6) | 52(9.2) | |
死亡组 | 19 | 77.8(68.6,81.8) | 11/8 | 2(2,7) | 12(63.2) | 11(57.9) | 12(63.2) | 3(15.8) | |
Z(χ2)值 | -1.682 | 0.021a | -6.378 | 6.949a | 4.224a | 0.049a | 0.922a | ||
P值 | 0.092 | 0.884 | 0.059 | 0.008 | 0.040 | 0.825 | 0.337 | ||
组别 | 肺循环障碍〔例(%)〕 | 心律失常〔例(%)〕 | 瓣膜病〔例(%)〕 | 周围血管病〔例(%)〕 | 脑血管病〔例(%)〕 | 肾衰竭〔例(%)〕 | 肝病〔例(%)〕 | 肥胖症〔例(%)〕 | 风湿性心脏病〔例(%)〕 |
生存组 | 49(8.7) | 253(44.9) | 48 (8.5) | 56 (9.9) | 137(24.3) | 89(15.8) | 23(4.1) | 32(5.7) | 0 |
死亡组 | 9(47.4) | 7(36.8) | 2(10.5) | 5(26.3) | 9(47.4) | 9(47.4) | 0 | 1(5.3) | 8(42.1) |
Z(χ2)值 | 30.697a | 0.487a | 0.094a | 5.268a | 5.164a | 12.990a | 0.808a | 0.082a | 0.273a |
P值 | <0.001 | 0.485 | 0.760 | 0.022 | 0.023 | <0.001 | 0.369 | 0.775 | 0.601 |
组别 | 肺源性心脏病〔例(%)〕 | 冠心病〔例(%)〕 | 心率〔M(P25,P75),次/min〕 | 平均动脉压〔M(P25,P75),mmHg〕 | 呼吸频率〔M(P25,P75),次/min〕 | 体温〔M(P25,P75),℃〕 | |||
生存组 | 7(1.2) | 411(72.9) | 86(74,101) | 97(87,110) | 20.00(19.00,22.00) | 36.30(36.20,36.50) | |||
死亡组 | 0 | 12(63.2) | 101(95,104) | 106(81,114) | 20.00(20.00,23.50) | 36.20(36.10,36.85) | |||
Z(χ2)值 | 0.239a | 0.871a | -2.677 | -1.260 | -1.981 | -0.132 | |||
P值 | 0.625 | 0.351 | 0.007 | 0.208 | 0.048 | 0.895 | |||
组别 | 血红蛋白〔M(P25,P75),g/L〕 | 阴离子间隙〔M(P25,P75),mmol/L 〕 | 尿素氮〔M(P25,P75),mmol/L 〕 | 肌酐〔M(P25,P75),μmol/L〕 | 葡萄糖〔M(P25,P75),mmol/L〕 | 钠〔M(P25,P75),mmol/L〕 | |||
生存组 | 129.00(113.00,144.00) | 10.20(8.10,11.80) | 7.41(5.54,11.57) | 84.15 (65.50,122.60) | 6.77(5.28, 9.67) | 138.00(135.00,141.00) | |||
死亡组 | 98.00 (86.50,124.50) | 15.90(9.70,19.70) | 28.48(9.66,31.38) | 170.50(110.40,277.60) | 9.70(8.08,14.54) | 141.00(137.50,146.50) | |||
Z(χ2)值 | -3.262 | -3.752 | -4.258 | -3.437 | -1.404 | -1.073 | |||
P值 | 0.001 | <0.001 | <0.001 | 0.001 | 0.160 | 0.283 | |||
组别 | 钾〔M(P25,P75),mmol/L〕 | 凝血酶原时间〔M(P25,P75),s〕 | 中性粒细胞计数〔M(P25,P75),×109/L〕 | 单核细胞计数〔M(P25,P75),×109/L〕 | 淋巴细胞计数〔M(P25,P75),×109/L〕 | NMLR〔M(P25,P75)〕 | |||
生存组 | 3.95(3.57,4.52) | 13.00(11.90,14.30) | 5.52(4.11,7.95) | 0.40(0.37,0.57) | 1.18(0.79,1.66) | 5.00(3.23,8.72) | |||
死亡组 | 4.10(3.75,4.41) | 12.90(12.60,16.35) | 6.17(4.34,6.82) | 0.44(0.34,0.62) | 0.89(0.73,1.73) | 8.36(3.15,9.55) | |||
Z(χ2)值 | -0.933 | -1.641 | -2.860 | -1.369 | -2.005 | -3.089 | |||
P值 | 0.351 | 0.101 | 0.004 | <0.001 | 0.045 | 0.002 |
Table 1 Compararion of baseline characteristics between the two groups
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 性别(男/女) | 住院时间〔M(P25,P75),d〕 | 感染〔例(%)〕 | 糖尿病〔例(%)〕 | 高血压〔例(%)〕 | 慢性阻塞性肺疾病〔例(%)〕 | |
---|---|---|---|---|---|---|---|---|---|
生存组 | 564 | 72.9(64.9,80.5) | 317/247 | 7(5,9) | 191(33.9) | 197(34.9) | 342(60.6) | 52(9.2) | |
死亡组 | 19 | 77.8(68.6,81.8) | 11/8 | 2(2,7) | 12(63.2) | 11(57.9) | 12(63.2) | 3(15.8) | |
Z(χ2)值 | -1.682 | 0.021a | -6.378 | 6.949a | 4.224a | 0.049a | 0.922a | ||
P值 | 0.092 | 0.884 | 0.059 | 0.008 | 0.040 | 0.825 | 0.337 | ||
组别 | 肺循环障碍〔例(%)〕 | 心律失常〔例(%)〕 | 瓣膜病〔例(%)〕 | 周围血管病〔例(%)〕 | 脑血管病〔例(%)〕 | 肾衰竭〔例(%)〕 | 肝病〔例(%)〕 | 肥胖症〔例(%)〕 | 风湿性心脏病〔例(%)〕 |
生存组 | 49(8.7) | 253(44.9) | 48 (8.5) | 56 (9.9) | 137(24.3) | 89(15.8) | 23(4.1) | 32(5.7) | 0 |
死亡组 | 9(47.4) | 7(36.8) | 2(10.5) | 5(26.3) | 9(47.4) | 9(47.4) | 0 | 1(5.3) | 8(42.1) |
Z(χ2)值 | 30.697a | 0.487a | 0.094a | 5.268a | 5.164a | 12.990a | 0.808a | 0.082a | 0.273a |
P值 | <0.001 | 0.485 | 0.760 | 0.022 | 0.023 | <0.001 | 0.369 | 0.775 | 0.601 |
组别 | 肺源性心脏病〔例(%)〕 | 冠心病〔例(%)〕 | 心率〔M(P25,P75),次/min〕 | 平均动脉压〔M(P25,P75),mmHg〕 | 呼吸频率〔M(P25,P75),次/min〕 | 体温〔M(P25,P75),℃〕 | |||
生存组 | 7(1.2) | 411(72.9) | 86(74,101) | 97(87,110) | 20.00(19.00,22.00) | 36.30(36.20,36.50) | |||
死亡组 | 0 | 12(63.2) | 101(95,104) | 106(81,114) | 20.00(20.00,23.50) | 36.20(36.10,36.85) | |||
Z(χ2)值 | 0.239a | 0.871a | -2.677 | -1.260 | -1.981 | -0.132 | |||
P值 | 0.625 | 0.351 | 0.007 | 0.208 | 0.048 | 0.895 | |||
组别 | 血红蛋白〔M(P25,P75),g/L〕 | 阴离子间隙〔M(P25,P75),mmol/L 〕 | 尿素氮〔M(P25,P75),mmol/L 〕 | 肌酐〔M(P25,P75),μmol/L〕 | 葡萄糖〔M(P25,P75),mmol/L〕 | 钠〔M(P25,P75),mmol/L〕 | |||
生存组 | 129.00(113.00,144.00) | 10.20(8.10,11.80) | 7.41(5.54,11.57) | 84.15 (65.50,122.60) | 6.77(5.28, 9.67) | 138.00(135.00,141.00) | |||
死亡组 | 98.00 (86.50,124.50) | 15.90(9.70,19.70) | 28.48(9.66,31.38) | 170.50(110.40,277.60) | 9.70(8.08,14.54) | 141.00(137.50,146.50) | |||
Z(χ2)值 | -3.262 | -3.752 | -4.258 | -3.437 | -1.404 | -1.073 | |||
P值 | 0.001 | <0.001 | <0.001 | 0.001 | 0.160 | 0.283 | |||
组别 | 钾〔M(P25,P75),mmol/L〕 | 凝血酶原时间〔M(P25,P75),s〕 | 中性粒细胞计数〔M(P25,P75),×109/L〕 | 单核细胞计数〔M(P25,P75),×109/L〕 | 淋巴细胞计数〔M(P25,P75),×109/L〕 | NMLR〔M(P25,P75)〕 | |||
生存组 | 3.95(3.57,4.52) | 13.00(11.90,14.30) | 5.52(4.11,7.95) | 0.40(0.37,0.57) | 1.18(0.79,1.66) | 5.00(3.23,8.72) | |||
死亡组 | 4.10(3.75,4.41) | 12.90(12.60,16.35) | 6.17(4.34,6.82) | 0.44(0.34,0.62) | 0.89(0.73,1.73) | 8.36(3.15,9.55) | |||
Z(χ2)值 | -0.933 | -1.641 | -2.860 | -1.369 | -2.005 | -3.089 | |||
P值 | 0.351 | 0.101 | 0.004 | <0.001 | 0.045 | 0.002 |
项目 | 单因素分析 | 多因素分析 | ||
---|---|---|---|---|
HR(95%CI) | P值 | HR(95%CI) | P值 | |
感染 | 2.614(1.020,6.698) | 0.045 | 1.133(0.760,1.690) | 0.539 |
糖尿病 | 2.003(0.789,5.080) | 0.144 | ||
肺循环障碍 | 6.326(2.460,12.267) | <0.001 | 0.954(0.544,1.672) | 0.869 |
周围血管病 | 3.346(1.177,9.515) | 0.023 | 0.958(0.571,1.608) | 0.872 |
脑血管病 | 2.305(0.918,5.786) | 0.075 | ||
肾衰竭 | 3.766(1.514,9.370) | 0.004 | 0.937(0.577,1.522) | 0.794 |
心率 | 1.026(1.006,1.047) | 0.013 | 0.995(0.986,1.004) | 0.306 |
呼吸频率 | 1.039(0.993,1.087) | 0.097 | ||
血红蛋白 | 0.969(0.955,0.93) | <0.001 | 0.993(0.986,1.000) | 0.042 |
阴离子间隙 | 1.246(1.143,1.358) | <0.001 | 1.062(1.009,1.118) | 0.021 |
尿素氮 | 1.094(1.060,1.129) | <0.001 | 1.011(0.985,1.036) | 0.413 |
肌酐 | 1.000(1.000,1.001) | 0.318 | ||
中性粒细胞 | 1.034(1.009,1.059) | 0.007 | 1.098(1.031,1.170) | 0.004 |
单核细胞 | 1.342(1.125,1.602) | 0.001 | 1.338(1.092,1.639) | 0.005 |
淋巴细胞 | 0.578(0.435,0.768) | <0.001 | 0.560(0.410,0.765) | <0.001 |
NMLR | 1.026(1.007,1.046) | 0.008 | 1.003(1.001,1.005) | 0.028 |
Table 2 Univariate and multivariate Cox analysis of influencing factors of in-hospital mortality in patients with HF
项目 | 单因素分析 | 多因素分析 | ||
---|---|---|---|---|
HR(95%CI) | P值 | HR(95%CI) | P值 | |
感染 | 2.614(1.020,6.698) | 0.045 | 1.133(0.760,1.690) | 0.539 |
糖尿病 | 2.003(0.789,5.080) | 0.144 | ||
肺循环障碍 | 6.326(2.460,12.267) | <0.001 | 0.954(0.544,1.672) | 0.869 |
周围血管病 | 3.346(1.177,9.515) | 0.023 | 0.958(0.571,1.608) | 0.872 |
脑血管病 | 2.305(0.918,5.786) | 0.075 | ||
肾衰竭 | 3.766(1.514,9.370) | 0.004 | 0.937(0.577,1.522) | 0.794 |
心率 | 1.026(1.006,1.047) | 0.013 | 0.995(0.986,1.004) | 0.306 |
呼吸频率 | 1.039(0.993,1.087) | 0.097 | ||
血红蛋白 | 0.969(0.955,0.93) | <0.001 | 0.993(0.986,1.000) | 0.042 |
阴离子间隙 | 1.246(1.143,1.358) | <0.001 | 1.062(1.009,1.118) | 0.021 |
尿素氮 | 1.094(1.060,1.129) | <0.001 | 1.011(0.985,1.036) | 0.413 |
肌酐 | 1.000(1.000,1.001) | 0.318 | ||
中性粒细胞 | 1.034(1.009,1.059) | 0.007 | 1.098(1.031,1.170) | 0.004 |
单核细胞 | 1.342(1.125,1.602) | 0.001 | 1.338(1.092,1.639) | 0.005 |
淋巴细胞 | 0.578(0.435,0.768) | <0.001 | 0.560(0.410,0.765) | <0.001 |
NMLR | 1.026(1.007,1.046) | 0.008 | 1.003(1.001,1.005) | 0.028 |
变量 | 灵敏度 | 特异度 | 约登指数 | 最佳截断值 | P值 | AUC | 95%CI |
---|---|---|---|---|---|---|---|
NMLR | 0.508 | 0.820 | 0.328 | 7.93 | <0.001 | 0.704 | (0.652,0.757) |
单核细胞计数 | 0.234 | 0.932 | 0.166 | 0.76×109/L | 0.003 | 0.585 | (0.525,0.646) |
中性粒细胞计数 | 0.492 | 0.719 | 0.211 | 6.15×109/L | <0.001 | 0.620 | (0.563,0.676) |
淋巴细胞计数 | 0.002 | 0.999 | 0.001 | 8.93×109/L | <0.001 | 0.341 | (0.289,0.393) |
Table 3 The predictive value of blood cell count indexes for predicting in-hospital mortality in patients with HF
变量 | 灵敏度 | 特异度 | 约登指数 | 最佳截断值 | P值 | AUC | 95%CI |
---|---|---|---|---|---|---|---|
NMLR | 0.508 | 0.820 | 0.328 | 7.93 | <0.001 | 0.704 | (0.652,0.757) |
单核细胞计数 | 0.234 | 0.932 | 0.166 | 0.76×109/L | 0.003 | 0.585 | (0.525,0.646) |
中性粒细胞计数 | 0.492 | 0.719 | 0.211 | 6.15×109/L | <0.001 | 0.620 | (0.563,0.676) |
淋巴细胞计数 | 0.002 | 0.999 | 0.001 | 8.93×109/L | <0.001 | 0.341 | (0.289,0.393) |
[1] |
Writing Committee Members,ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure[J]. J Card Fail,2022,28(5):e1-167. DOI:10.1016/j.cardfail.2022.02.010.
|
[2] |
王华,李莹莹.慢性心力衰竭加重患者的综合管理中国专家共识2022[J].中国循环杂志,2022,37(3):215-225.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志,2018,46(10):760-789. DOI:10.3760/cma.j.issn.0253-3758.2018.10.004.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
唐超,雍莉,刘火五沙,等. 中性粒细胞与淋巴细胞比值与心力衰竭合并心房颤动患者疾病严重程度相关性分析[J]. 临床急诊杂志,2018,19(5):283-287. DOI:10.13201/j.issn.1009-5918.2018.05.002.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
[1] | LIU Ailing, ZHOU Jingjing, LI Chengcheng, HE Kaiyue, LIANG Shanshan, ZHOU Shangcheng. Analysis of the Disease Burden Trends and Death Projections for Esophageal Cancer Attributable to Tobacco in China from 1990 to 2019 [J]. Chinese General Practice, 2023, 26(36): 4587-4594. |
[2] | CHENG Hao, ZHOU Jinchi, LIU Xi, KANG Lin, FAN Ahui, DOU Weijia, LIU Zhenxiong. Risk Factors Analysis and Risk Prediction Model Establishment for Rebleeding Events within 3 Years after Endoscopic Treatment of Gastroesophageal Varices in Liver Cirrhosis Patients [J]. Chinese General Practice, 2023, 26(35): 4446-4452. |
[3] | ZHU Wenpeng, HAN Mengqi, WANG Yuxin, WANG Guoping. Trends and Projections of Incidence and Mortality of Nasopharyngeal Carcinoma in China from 1990 to 2019 [J]. Chinese General Practice, 2023, 26(34): 4269-4276. |
[4] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[5] | MA Liyuan, WANG Zengwu, FAN Jing, HU Shengshou. Interpretation of Report on Cardiovascular Health and Diseases in China 2022 [J]. Chinese General Practice, 2023, 26(32): 3975-3994. |
[6] | DENG Jingjing, LI Xia, XUE Qian, DENG Lihua, WANG Jingtong. The Efficacy of Continuous Airway Positive Pressure Ventilation on OSA Complicated with GERD: an Observational Study [J]. Chinese General Practice, 2023, 26(30): 3753-3758. |
[7] | ZHANG Zhendong, CAI Bin, WANG Hongwei, QIAO Zengyong. Study on the Changes of Intestinal Flora and Its Metabolite Phenylacetylglutamine in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2023, 26(29): 3665-3673. |
[8] | XU Zhe, ZHANG Jinxia, ZHANG Xiuhong, XIE Kaihong. Relationship between Sleep Duration and All-cause Mortality in Middle-aged and Older Adults [J]. Chinese General Practice, 2023, 26(28): 3507-3512. |
[9] | FEI Sijie, ZHANG Qiang, LIU Fangfang, BAI Lu, SUN Caihong, XIN Caifeng. Correlation between Glycated Hemoglobin Variability and New-onset Atrial Fibrillation in Type 2 Diabetes Patients Combined with Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2023, 26(26): 3246-3251. |
[10] | SUN Xuhai, SHI Xiuxiu, ZHAO Zhengzheng, HAN Jinxiang. Characteristics of Newly Increased and Deceased Patients with Severe Mental Illness in a Community in Beijing from 2011 to 2021 [J]. Chinese General Practice, 2023, 26(19): 2402-2407. |
[11] | LIANG Shanshan, ZHOU Zhihua, LI Chengcheng, CHEN Huijing, ZHOU Shangcheng. Diabetes in China: Burden Analysis between 1990 and 2019 and Incidence Prediction between 2020 and 2030 [J]. Chinese General Practice, 2023, 26(16): 2013-2019. |
[12] | SONG Hualong, GAO Ying. Association between Serum Uric Acid and the Risk of Type 2 Diabetes Mellitus: a Population-based Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(15): 1831-1839. |
[13] | YUE Bocheng, HOU Qiqi, HAN Quanle, YANG Bo, WU Zheng, WU Jianmei, CHEN Shuohua, WU Shouling, LI Kangbo. Effect of Atrial Fibrillation on the Risk of New-onset Myocardial Infarction in Hypertensive Population [J]. Chinese General Practice, 2023, 26(14): 1739-1744. |
[14] | CHEN Ruimin, LIU Fang, TAN Hong, HAN Shufang, CHEN Yingjian, SU Congcong. Effects of Dapagliflozin on the Expression of MicroRNA-423-5p and Cardiac Function in Patients with Type 2 Diabetes Mellitus and Chronic Heart Failure [J]. Chinese General Practice, 2023, 26(14): 1733-1738. |
[15] | HUANG Pengfei, ZHANG Yunjing, MA Dong, WU Yunyan, ZHAO Yongbo. Relationship between Admission Serum Chloride Level and Postoperative 30-day Mortality in Patients with Acute Stanford Type A Aortic Dissection [J]. Chinese General Practice, 2023, 26(11): 1330-1339. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||